TP53 and neoplasm: By dividing mutations into early and late events, literature separates the initial drivers of neoplasia, such as BRAF and RAS, and late mutations such as TERT, TP53, PTEN, and PIK3CA rearrangements that account for dedifferentiation and aggressive behavior [17,18,72].